Literature DB >> 30429568

Genetically modified T cells target lymphoma.

Bianca Nogrady.   

Abstract

Entities:  

Keywords:  Cancer; Immunology; Medical research; Therapeutics

Mesh：

Substances：

Year:  2018        PMID： 30429568     DOI： 10.1038/d41586-018-07361-6

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  1 in total

1.  Clinical and immunological responses after CD30-specific chimeric antigen receptor-redirected lymphocytes.

Authors:  Carlos A Ramos; Brandon Ballard; Huimin Zhang; Olga Dakhova; Adrian P Gee; Zhuyong Mei; Mrinalini Bilgi; Meng-Fen Wu; Hao Liu; Bambi Grilley; Catherine M Bollard; Bill H Chang; Cliona M Rooney; Malcolm K Brenner; Helen E Heslop; Gianpietro Dotti; Barbara Savoldo
Journal:  J Clin Invest       Date:  2017-08-14       Impact factor: 14.808
  1 in total
  1 in total

Review 1.  Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives.

Authors:  Itziar Gómez-Aguado; Julen Rodríguez-Castejón; Mónica Vicente-Pascual; Alicia Rodríguez-Gascón; María Ángeles Solinís; Ana Del Pozo-Rodríguez
Journal:  Nanomaterials (Basel)       Date:  2020-02-20       Impact factor: 5.076
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.